The following patents & patent applications are licensed from Advanced Cell Technology, Inc.
A BTX/ACTC merger would be nice!
Biotime needs ACTC IPS cell technology, personalized therapy CANNOT be done without this IP.
Sentiment: Strong Buy
Yes, ACTC and BTX are tight.